MENU
+Compare
GUTS
Stock ticker: NASDAQ
AS OF
May 23, 02:10 PM (EDT)
Price
$1.76
Change
+$0.01 (+0.57%)
Capitalization
85.95M

GUTS Fractyl Health Forecast, Technical & Fundamental Analysis

Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity... Show more

GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GUTS with price predictions
May 22, 2025

GUTS in upward trend: 10-day moving average moved above 50-day moving average on May 02, 2025

The 10-day moving average for GUTS crossed bullishly above the 50-day moving average on May 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 2 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on GUTS as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

GUTS moved above its 50-day moving average on May 02, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where GUTS advanced for three days, in of 49 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 6 cases where GUTS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GUTS moved out of overbought territory on May 21, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 1 similar instances where the indicator moved out of overbought territory. In of the 1 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 10 cases where GUTS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GUTS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GUTS broke above its upper Bollinger Band on May 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GUTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.477) is normal, around the industry mean (16.302). P/E Ratio (0.000) is within average values for comparable stocks, (59.789). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.190). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1428.571) is also within normal values, averaging (277.726).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GUTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

GUTS is expected to report earnings to fall 9.09% to -43 cents per share on August 13

Fractyl Health GUTS Stock Earnings Reports
Q2'25
Est.
$-0.43
Q1'25
Missed
by $0.06
Q4'24
Missed
by $0.10
The last earnings report on May 13 showed earnings per share of -47 cents, missing the estimate of -40 cents. With 39.59K shares outstanding, the current market capitalization sits at 85.95M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3 Van de Graaff Drive
Phone
+1 781 902-8800
Employees
102
Web
https://www.fractyl.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HEQFX4.60N/A
N/A
Monteagle Opportunity Equity Inv
EIVCX13.18N/A
N/A
Allspring Special Large Cap Value C
VSCAX22.00N/A
N/A
Invesco Small Cap Value A
MXIGX13.96N/A
N/A
Empower International Growth Inv
GCINX15.18N/A
N/A
Green Century MSCI Intl Indx Indvl Inv

GUTS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with CABA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then CABA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-4.62%
CABA - GUTS
36%
Loosely correlated
-0.84%
YMAB - GUTS
36%
Loosely correlated
N/A
IPSC - GUTS
35%
Loosely correlated
-0.93%
AKBA - GUTS
35%
Loosely correlated
+0.71%
GLUE - GUTS
35%
Loosely correlated
+1.00%
More